282 related articles for article (PubMed ID: 12738392)
1. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.
Keenan JI; Rijpkema SG; Durrani Z; Roake JA
FEMS Immunol Med Microbiol; 2003 May; 36(3):199-205. PubMed ID: 12738392
[TBL] [Abstract][Full Text] [Related]
2. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
Nyström J; Raghavan S; Svennerholm AM
Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
[TBL] [Abstract][Full Text] [Related]
5. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
Kubota E; Joh T; Tanida S; Sasaki M; Kataoka H; Watanabe K; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Yamada T; Mori Y; Fujita F; Shimura T; Ohara H; Isaka M; Yasuda Y; Itoh M
Helicobacter; 2005 Aug; 10(4):345-52. PubMed ID: 16104951
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
7. Orogastric vaccination of guinea pigs with Helicobacter pylori sonicate and a high dose of cholera toxin lowers the burden of infection.
Durrani Z; Rijpkema S
FEMS Immunol Med Microbiol; 2003 May; 36(3):169-73. PubMed ID: 12738387
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
Kim SY; Doh HJ; Jang MH; Ha YJ; Chung SI; Park HJ
Helicobacter; 1999 Mar; 4(1):33-9. PubMed ID: 10352085
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of vaccines based on the Helicobacter suis urease subunit B and γ-glutamyl transpeptidase.
Vermoote M; Flahou B; Pasmans F; Ducatelle R; Haesebrouck F
Vaccine; 2013 Jul; 31(32):3250-6. PubMed ID: 23707444
[TBL] [Abstract][Full Text] [Related]
10. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
11. Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate.
Keenan J; Oliaro J; Domigan N; Potter H; Aitken G; Allardyce R; Roake J
Infect Immun; 2000 Jun; 68(6):3337-43. PubMed ID: 10816482
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
13. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
[TBL] [Abstract][Full Text] [Related]
14. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
[TBL] [Abstract][Full Text] [Related]
16. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
17. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
18. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
[TBL] [Abstract][Full Text] [Related]
19. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine.
Talebkhan Y; Bababeik M; Esmaeili M; Oghalaei A; Saberi S; Karimi Z; Afkhami N; Mohammadi M
J Microbiol Methods; 2010 Sep; 82(3):334-7. PubMed ID: 20621134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]